Beyond Traditional Screening: The Commercial Potential of Contrast-Enhanced Mammography

0
5

Can Contrast-Enhanced Mammography (CEM) bridge the gap between screening and MRI?

Contrast-enhanced mammography (CEM) is emerging as a powerful, cost-effective alternative to Breast MRI for high-risk patients. While MRI remains the gold standard for sensitivity, its high cost and limited availability create access barriers. CEM utilizes existing mammography equipment with the addition of intravenous contrast agents, providing functional vascular information similar to MRI but at a fraction of the cost.

For strategy heads at diagnostic centers, CEM offers a way to diversify their service portfolio without investing millions in a new MRI suite. It allows for more efficient preoperative planning and better assessment of treatment response in oncology patients, making it a high-value tool for integrated breast centers.

How are Breast Cancer Diagnostic Trends shifting toward functional imaging?

Current Breast Cancer Diagnostic Trends indicate a move toward "precision diagnostics." In 2024, clinicians are looking for ways to reduce the "grey area" of inconclusive mammograms. CEM provides the functional data necessary to make definitive decisions, reducing the time from screening to treatment—a key metric for patient outcomes and hospital reputation.

What are the procurement considerations for CEM?

Implementing CEM requires hardware that supports dual-energy acquisition and the integration of contrast injectors. Procurement teams must also consider the additional training required for technicians and the logistics of contrast agent management. In 2025, we expect a rise in "upgrade kits" that allow existing 3D systems to perform CEM.

Criteria

Standard Digital Mammography

Contrast-Enhanced Mammography (CEM)

Information Type

Morphological (Anatomy)

Functional (Vascularity)

Cost per Scan

Low

Moderate

Procedure Time

5-10 minutes

10-15 minutes

Strategic Outlook for 2025

In 2025, CEM is projected to become the standard of care for supplemental screening in women with dense breasts who cannot undergo MRI. Diagnostic centers that adopt this early will capture a high-margin patient segment and differentiate themselves in an increasingly competitive imaging market.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | info@marketresearchfuture.com

Rechercher
Catégories
Lire la suite
Autre
Aircraft Transparencies Market Growth Drivers: Share, Value, Size, and Insights By 2032
Executive Summary Aircraft Transparencies Market Size, Share, and Competitive...
Par Travis Rosher 2025-11-05 11:44:22 0 194
Autre
Global Phthalic Anhydride Market Overview: Key Trends and Emerging Opportunities
The Phthalic Anhydride Market has witnessed significant growth over the past decade, driven by...
Par Devendra Bandsihti 2025-10-15 10:33:58 0 261
Health
A Multi-Layered Defense: Integrating Vaccination with Existing Malaria Control Strategies
Malaria vaccines are not intended to be a standalone solution but rather a powerful,...
Par Anuj Mrfr 2025-12-05 13:30:30 0 135
Autre
Global MDR Market — Strategic Growth Outlook & Forecast 2025–2034
Polaris Market Research has published a brand-new report titled Managed Detection and...
Par Shruti Garud 2025-11-19 10:25:29 0 170
Art
Metastatic Castrate Resistant Prostate Cancer Treatment Market Future Scope: Growth, Share, Value, Size, and Analysis
"The global metastatic castrate resistant prostate cancer treatment market size was valued...
Par Aryan Mhatre 2025-10-10 08:20:14 0 363